Cargando…

Factors Influencing Fluoroquinolone Resistance

Detalles Bibliográficos
Autores principales:	Sahm, Daniel F., Thornsberry, Clyde, Jones, Mark E., Karlowsky, James A.
Formato:	Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2003
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034343/ https://www.ncbi.nlm.nih.gov/pubmed/14725310 http://dx.doi.org/10.3201/eid0912.03-168

Ejemplares similares

Emerging resistance among bacterial pathogens in the intensive care unit – a European and North American Surveillance study (2000–2002)
por: Jones, Mark E, et al.
Publicado: (2004)

Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002
por: Karlowsky, James A, et al.
Publicado: (2004)

Tracking the implementation of NCCLS M100-S12 expanded-spectrum cephalosporin MIC breakpoints for nonmeningeal isolates of Streptococcus pneumoniae by clinical laboratories in the United States during 2002 and 2003
por: Master, Ronald N, et al.
Publicado: (2004)

Activity of ceftriaxone and comparator agents against bacterial pathogens isolated from central nervous system (CNS) (meningeal) specimens: TSN Database USA 2000–2002
por: Jones, ME, et al.
Publicado: (2003)

Fluoroquinolone-resistant Streptococcus pneumoniae
por: Pletz, Mathias W.R., et al.
Publicado: (2006)

Fluoroquinolone-Resistant Typhoid, South Africa
por: Keddy, Karen H., et al.
Publicado: (2010)

Fluoroquinolone-resistant Salmonella Paratyphi A
por: Adachi, Takuya, et al.
Publicado: (2005)

Fluoroquinolone-resistant Salmonella sp. in Carcasses
por: Wang, Yu-Chih, et al.
Publicado: (2006)

In vitro activity of imipenem ± aminoglycosides against Pseudomonas aeruginosa and Acinetobacter calcoaceticus / baumanii isolated from patients in ICUs in German hospitals (1999–2002)
por: Mueller, EE, et al.
Publicado: (2003)

Fluoroquinolone-Resistant Mycoplasma genitalium, Southwestern France
por: Le Roy, Chloé, et al.
Publicado: (2016)

Fluoroquinolone-Resistant Group B Streptococci in Acute Exacerbation of Chronic Bronchitis
por: Tazi, Asmaa, et al.
Publicado: (2008)

gyrA Mutations in Fluoroquinolone-resistant Clostridium difficile PCR-027
por: Drudy, Denise, et al.
Publicado: (2007)

Fluoroquinolone Use in Food Animals
por: Collignon, Peter
Publicado: (2005)

Fluoroquinolones: An under-recognized cause for delirium
por: Chowdhry, Vivek, et al.
Publicado: (2015)

Discovery of a Fluoroquinolone-Resistant Serratia marcescens Clinical Isolate without Quinolone Resistance-Determining Region Mutations
por: Yang, Haifei, et al.
Publicado: (2014)

Antioxidant therapy in the management of fluoroquinolone-associated disability
por: Pietruszyński, Robert, et al.
Publicado: (2020)

Prevalence of antimicrobial resistance in bacteria isolated from central nervous system specimens as reported by U.S. hospital laboratories from 2000 to 2002
por: Jones, Mark E, et al.
Publicado: (2004)

In Vitro Activity of Ceftibuten/VNRX-5236 against Urinary Tract Infection Isolates of Antimicrobial-Resistant Enterobacterales
por: Karlowsky, James A., et al.
Publicado: (2022)

Chromosomal Locations of mcr-1 and bla(CTX-M-15) in Fluoroquinolone-Resistant Escherichia coli ST410
por: Falgenhauer, Linda, et al.
Publicado: (2016)

In the Quest of Drugs for Bad Bugs: Are Newer Fluoroquinolones Any Better?
por: Deep, Antariksh, et al.
Publicado: (2011)

Fluoroquinolone-Resistant Mycobacterium tuberculosis, Pakistan, 2005–2009
por: Jabeen, Kauser, et al.
Publicado: (2011)

National antimicrobial stewardship and fluoroquinolone-resistant Clostridium difficile in China
por: Xiao, Meng, et al.
Publicado: (2017)

Fluoroquinolone preventive therapy for children exposed to MDR-TB
por: Gureva, T., et al.
Publicado: (2022)

Ceftibuten-Ledaborbactam Activity against Multidrug-Resistant and Extended-Spectrum-β-Lactamase-Positive Clinical Isolates of Enterobacterales from a 2018–2020 Global Surveillance Collection
por: Karlowsky, James A., et al.
Publicado: (2022)

Mycoplasma genitalium macrolide and fluoroquinolone resistance in pregnant women in Papua New Guinea
por: Jonduo, Marinjho E, et al.
Publicado: (2023)

Epidemiology and in vitro activity of ceftazidime-avibactam and comparator agents against multidrug-resistant isolates of Enterobacterales and Pseudomonas aeruginosa collected in Latin America as part of the ATLAS surveillance program in 2015‒2020
por: Wise, Mark G., et al.
Publicado: (2023)

Presence of plasmid-mediated quinolone resistance (PMQR) genes in non-typhoidal Salmonella strains with reduced susceptibility to fluoroquinolones isolated from human salmonellosis in Gyeonggi-do, South Korea from 2016 to 2019
por: Lee, Sohyun, et al.
Publicado: (2021)

In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against Carbapenem-Nonsusceptible and Multidrug-Resistant Isolates of Gram-Negative Bacilli Collected Worldwide in 2014 to 2016
por: Hackel, Meredith A., et al.
Publicado: (2018)

Risk Factors for Fluoroquinolone Resistance in Ocular Cultures
por: Lee, Junsung, et al.
Publicado: (2015)

In vitro activity of aztreonam–avibactam against Enterobacterales isolates collected in Latin America, Africa/Middle East, Asia, and Eurasia for the ATLAS Global Surveillance Program in 2019–2021
por: Wise, Mark G., et al.
Publicado: (2023)

Resistance among Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Latin American countries: SMART 2013–2015
por: Karlowsky, James A., et al.
Publicado: (2017)

Fluoroquinolone-Resistant Alcaligenes faecalis Related to Chronic Suppurative Otitis Media, Angola
por: Filipe, Matuba, et al.
Publicado: (2017)

Maintaining Fluoroquinolone Class Efficacy: Review of Influencing Factors
por: Scheld, W. Michael
Publicado: (2003)

Fluoroquinolone-resistant Escherichia coli, Indonesia
por: Kuntaman, Kuntaman, et al.
Publicado: (2005)

Limited Scope of Shorter Drug Regimen for MDR TB Caused by High Resistance to Fluoroquinolone
por: Singh, Pravin K., et al.
Publicado: (2019)

In Vitro Activity of Ceftibuten-Avibactam against β-Lactamase-Positive Enterobacterales from the ATLAS Global Surveillance Program
por: Karlowsky, James A., et al.
Publicado: (2023)

DELAFLOXACIN, A NOVEL FLUOROQUINOLONE ANTIBIOTIC WITH ACTIVITY AGAINST HOSPITAL-, COMMUNITY- AND LIVESTOCK- ASSOCIATED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA)
por: Maguire, Mollie, et al.
Publicado: (2021)

Do fluoroquinolones actually increase mortality in community-acquired pneumonia?
por: Agarwal, Ritesh
Publicado: (2006)

Fluoroquinolones compared to 1% azithromycin in DuraSite(®) for bacterial conjunctivitis
por: Lichtenstein, Steven J, et al.
Publicado: (2008)

Fluoroquinolone resistance in Neisseria gonorrhoeae.
por: Knapp, J S, et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_5btqhbu4tphopoa6p91f3pibej